Filing Details

Accession Number:
0001209191-11-046179
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-31 17:33:28
Reporting Period:
2011-08-29
Filing Date:
2011-08-31
Accepted Time:
2011-08-31 17:33:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333170 Nxstage Medical Inc. NXTM Electromedical & Electrotherapeutic Apparatus (3845) 043454702
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1162977 Perper Reid C/O Nxstage Medical, Inc.
439 South Union Street, 5Th Floor
Lawrence MA 01843
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-08-29 20,000 $18.42 181,713 No 4 S Direct
Common Stock Disposition 2011-08-30 30,000 $18.44 151,713 No 4 S Direct
Common Stock Disposition 2011-08-31 28,540 $18.71 123,173 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.36 to $18.46. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.35 to $18.70. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.5 to $18.85. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.